Clinical trial
A Phase 1 Single Ascending Dose Study of ASKP1240 in Healthy Male and Female Volunteers
NCT01565681 is registered in ClinicalTrials.gov with Astellas Pharma Global Development, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 1 Single Ascending Dose Study of ASKP1240 in Healthy Male and Female Volunteers
- Lead sponsor
- Astellas Pharma Global Development, Inc.
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- January 31, 2009
- Completion date
- December 31, 2009
- Enrollment
- 109 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
healthy volunteers, pharmacokinetics of askp1240